secwatch.observer — SEC 8-K summary
======================================

Issuer:     HENRY SCHEIN INC (HSIC)
CIK:        0001000228
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001000228-23-000041
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Henry Schein Q2 GAAP EPS $1.06, Non-GAAP $1.31; Revenue $3.1B; Affirms FY Guidance
--------------------------------------------------------------------------------

- GAAP net income $140M ($1.06/diluted share) vs Q2 2022 $160M ($1.16); non-GAAP $173M ($1.31) vs $179M ($1.30).
- Total sales $3.1B (+2.3%); internal sales ex-PPE/COVID test kits +3.3% in local currencies; global dental +5.6% to $2.0B.
- PPE & COVID test kit sales $163M, down $96M YoY; impact on EPS estimated at $0.08/diluted share.
- FY 2023 non-GAAP EPS guidance reaffirmed at $5.18-$5.35; PPE sales now expected to decline 25%-30% (prior ~20-25%).
- Committed over $1B to acquisitions YTD; closed new $750M credit facility in July 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/0001000228-23-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/hsic-20230807.htm
  HTML page:      https://secwatch.observer/filing/0001000228-23-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer